Rheinmetall's CEO Spends €702,780 as Bernstein Cuts to Market-Perform
Published on 11/08/2026 at 18:11 | Editorial boerse-global.de
Rheinmetall closed out a turbulent week with two purchases by its chief executive totaling €702,780 — a personal vote of confidence filed just as Bernstein Research pulled its bullish stance on the stock. The insider buying, disclosed in mandatory filings, saw Armin Theodor Papperger acquire shares worth €502,484.40 on Thursday and a further €200,295.60 on Friday.
The timing matters because the same Thursday brought third-quarter results that cut both ways. Operating profit for the quarter came in at €553 million, up 62% year on year, on a margin of 17.5%. Over the first nine months, sales reached €8.4 billion — a 38% advance — while operating profit climbed 69% to €1.34 billion, a 16.0% margin. The second source puts the nine-month figure at €1.339 billion with a 68% increase, a rounding difference in the same result.
Cash flow tells a different story
What the headline numbers mask is a negative operating free cash flow of €1.7 billion for the nine-month period. Rheinmetall attributed the outflow to inventory build-up intended to support the sales growth it is targeting. In plain terms, the profit engine is running hot while the cash till stays empty — a gap investors will want to see narrow.
The backdrop to those results is Wednesday's guidance cut. Rheinmetall now expects roughly €13.2 billion in 2026 revenue, down from a previous range of €13.7 billion to €14.2 billion. The projected operating margin was trimmed to around 18.5% from approximately 19%. Management blamed likely delays in the awarding of the Boxer project Arminius and in lot acceptances for artillery ammunition.
Should investors sell immediately? Or is it worth buying Rheinmetall?
The money moves to 2027
Arminius advance payments and revenue contributions, along with the postponed ammunition sales, are now expected to land in 2027, according to the company. With the quarterly release, Rheinmetall confirmed the revised full-year expectations.
That deferral is the crux of the investment case. A delayed contract award and a later lot acceptance are distinct steps in the chain, but either can keep Rheinmetall from booking expected revenue inside the planned window. The growth potential is not in question so much as its timing.
Bernstein's move on Friday sharpened the debate. The broker reportedly cut its price target to €1,000 from €1,200 and downgraded the shares to "Market-Perform" from "Outperform" — a more cautious valuation that argues against an unreservedly optimistic reading of the insider purchases.
What the bull case still has
The favorable scenario rests on the nine-month figures: a business expanding at 38% with margins in the mid-teens can keep growing, provided the delays prove finite and the affected revenue is subsequently realized. On that reading, a lower annual forecast sits alongside a still-growing operating base. Papperger's purchases fit that picture, and their weight as a confidence signal would grow once operational progress points the same way.
Rheinmetall at a turning point? This analysis reveals what investors need to know now.
The counterargument links revenue risk to earnings risk. If awards or lot acceptances slip again, the hoped-for relief in the following year could slide further, forcing another round of estimate revisions. Execution risk, in that case, touches both the timing of sales and the profit attached to them.
Hamburg is the next checkpoint
The announced capital markets day in Hamburg on 26–27 November 2026 now becomes the key date on the calendar. What matters most there is whether Rheinmetall can make the link between contract awards, acceptances and revenue recognition more concrete. The firmer that implementation path looks, the stronger the fundamental case for a recovery. If it stays vague, the operational risks will keep carrying heavy weight — Papperger's own money notwithstanding.
Ad
Rheinmetall Stock: New Analysis - 8 November
Fresh Rheinmetall information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
